AmbitCare provides free genetic counseling and testing to those who qualify. We are proud to partner with AmbitCare to provide these services to our community.

Through their symptom survey for undiagnosed individuals, AmbitCare hopes to find more people with KCNT1 gene variants.

COMBINEDBrain is a nonprofit consortium devoted to speeding the path to clinical treatments for people with severe rare genetic non-verbal neurodevelopmental disorders by pooling efforts, studies, and data.

In addition to sharing resources and advocating for rare diseases, COMBINEDBrain also helps manage the KCNT1 Epilepsy Foundation biorepository so that researchers can compare rare genetic epilepsies.

The Clinical Research ID (CRID) is a service that enables people involved in clinical research to safely create their own unique universal ID.

We use CRID to connect various research efforts within our community and network of researchers, including the KCNT! Patient Research Registry.

DEE-P Connections seeks to facilitate connections and share critical resources between the many families impacted by DEEs (developmental epileptic encephalopathies).

Together with many other rare epilepsy foundations, we partner with DEE-P Connections to organize webinars and share and distribute resources between communities.

The KCNT1 Epilepsy foundation partners with Genetic Alliance to operate the KCNT1 Patient Research Registry: a secure platform where KCNT1 families can take part in KCNT1 research by taking surveys and sharing other health information.

Genetic Alliance is a nonprofit that provides training and support to communities building patient registries and conducting research.

Global Genes is a 501(c)(3) non-profit organization dedicated to eliminating the burdens and challenges of rare diseases for patients and families globally. They fulfill this mission by helping patients find and build communities, gain access to information and resources, connect to researchers, clinicians, industry, government, and other stakeholders, share data and experiences, stand up, stand out, and become effective advocates on their own behalf.

The KCNT1 Epilepsy Foundation is partnering with Ciitizen to conduct a digital natural history study.

Families living in the United States can use Ciitizen to gather all their child’s medical records and notes in one place, and then safely share those records with doctors for new consults, or with KCNT1 researchers to help improve our understanding of the disease.

We are now a participating organization of The Research Acceleration and Innovation Network (TRAIN) with FasterCures. We look forward to contributing to and learning from this unique program for patient-driven nonprofit foundations that fund medical research across a spectrum of diseases.

The Orphan Disease Center of the University of Pennsylvania Perelman School of Medicine operates the JumpStart Program, which connects patients and foundations to researchers and key opinion leaders, encouraging scientific collaboration. The KCNT1 Epilepsy Foundation is a participant in the JumpStart Program.

The KCNT1 Epilepsy Foundation is a proud member of the Rare Epilepsy Network (REN), together with many other rare epilepsy organizations and communities. REN works with urgency to collaboratively improve outcomes of rare epilepsy patients and families by fostering patient-focused research and advocacy.

Dr Leanne Dibbens at her lab at UNISA co-discovered the role of KCNT1 in epilepsy and continue to investigate how KCNT1 mutations cause epilepsy. They use genetic engineering to create a variety of genetic models with KCNT1 mutations. They are using these genetic models to identify FDA-approved drugs which are more specific to KCNT1, and could minimize the effects of the KCNT1 mutations, with the rationale that these drugs may be better for treating KCNT1-epilepsies.

The lab, led by Matthew Weston, Ph.D., studies gene variants that cause human childhood epilepsies and seeks to understand how they alter neuronal physiology to cause network hyperexcitability and seizures.

A comprehensive, one-stop hub of resources local to you, and reviews for those hard-to-find services your family needs. With our easy-to-use filters, narrowing your search to find therapists, recreational activities, advocates, and other resources in your area has never been easier.

SAMi The Sleep Activity Monitor™ is a wearable-free system for parents, caregivers, and individuals that need to monitor closely for abnormal or potentially dangerous movements during sleep or rest.

CURE is a leading nongovernmental agency fully committed to funding research to find the cure for all epilepsies. We be pleased to be joint partners, co-funding past and a future research grant to accelerate progress on KCNT1 Epilepsy Foundation’s research priorities.